INTRODUCTION
The prevalence of obesity has grown at an alarming rate, reaching pandemic proportions. One-third of U.S. adults are obese, leading to increased numbers of patients affected by the comorbidities of obesity, such as cardiovascular disease, type 2 diabetes, respiratory disorders, and cancer (Wang et al., 2011) . Considering the staggering cost and serious challenges to public health associated with this condition, identification of biochemical pathways that can be effectively and safely targeted for obesity therapy has acquired new urgency.
Hypothalamic neurons expressing Agouti-related peptide (AgRP) have been directly implicated in promoting feeding. AgRP neuron activation by either light-gated Channelrhodopsin-2 or ligand-activated G proteins rapidly increases food intake (Aponte et al., 2011; Krashes et al., 2011) . Conversely, acute ablation of AgRP neurons in adulthood causes cessation of feeding and results in starvation (Luquet et al., 2005) . Despite the established functional importance of AgRP neurons in feeding behavior, genetic analyses of specific hormonal pathways that impinge on this process have yielded limited and occasionally conflicting results. For example, transgenic overexpression of Agrp results in obesity, and acute intracerebroventricular (ICV) delivery of AgRP or neuropeptide Y (NPY), another peptide produced in AgRP neurons, elicits hyperphagia (Levine et al., 2004; Ollmann et al., 1997; Rossi et al., 1998) . However, mice with loss of Agrp, Npy, or both exhibit no feeding or body weight phenotypes and maintain a normal response to starvation (Qian et al., 2002) .
The key anorexigenic hormones, insulin and leptin, inhibit AgRP neurons, raising their activation threshold Takahashi and Cone, 2005) . Surprisingly, though, genetic ablation of insulin receptor in AgRP neurons has no effect on energy homeostasis, even as it impairs insulin-mediated suppression of hepatic glucose production . Similarly, inactivation of leptin receptors in AgRP neurons results in a mild increase of body weight without affecting feeding behavior and energy balance (van de Wall et al., 2008) . Thus, neither pathway appears to exert obligate control over AgRP-neuron-dependent feeding and energy homeostasis.
The goal of this study was twofold: (1) to solve the apparent paradox of the absence of food intake abnormalities following ablation of leptin or insulin receptors and (2) to identify alternative pathways that regulate AgRP-neuron-dependent food intake. To this end, we adopted a two-pronged strategy. As transcription factor FoxO1 integrates both leptin and insulin signaling (Kim et al., 2006; Kitamura et al., 2006) , it is plausible that greater effects in AgRP neurons might be engendered by FoxO1 ablation. Therefore, we knocked out FoxO1 in AgRP neurons with the intent to bring about a metabolic and energy balance phenotype that recapitulated constitutive insulin and leptin signaling in this cell type. We found that mice lacking FoxO1 in AgRP neurons are lean, eat less, and show improved glucose homeostasis as well as increased insulin/leptin sensitivity. Having achieved this goal, we sought to identify FoxO1-dependent pathways that modulate energy homeostasis and can be enlisted to develop antiobesity medications. Using transcriptional profiling of flow-sorted AgRP neurons lacking FoxO1 and functional in vivo and ex vivo testing, we identified Gpr17, a purinergic G-protein-coupled receptor, as a prominent FoxO1 target whose pharmacological inhibition reduces food intake and increases brain sensitivity to hormones and nutrients. ;Rosa-Tomato mice displayed a red fluorescence pattern in the arcuate nucleus (ARH) that was consistent with AgRP neuron localization ( Figure 1A ). We did not detect differences in the relative number or size of ARH AgRP neurons between wild-type and Agrp-Foxo1 À/À mice. Immunohistochemistry indicated that FoxO1 was highly expressed in ARH neurons, including AgRP neurons, of wild-type mice but was selectively undetectable in AgRP neurons of Agrp-Foxo1 À/À mice ( Figure 1A ).
RESULTS

Generation and Analysis of
Improved Energy Homeostasis in
Body weight of female and male Agrp-Foxo1 À/À mice was comparable to wild-type controls or trended lower without reaching statistical significance ( Figure 1B ). Both female and male Agrp-Foxo1 À/À mice showed altered body composition, with a remarkable 18%-30% decrease of fat mass and a significant 3%-5% increase of lean mass ( Figure 1C ). We selected male mice of matched body weight and composition for calorimetry studies. We measured respiratory exchanges, energy expenditure, and food intake. When fed ad libitum, Agrp-Foxo1 À/À mice were comparable to wild-type controls with regard to oxygen consumption (VO 2 ), respiratory quotient (RQ), and energy expenditure (Figures S1A-S1C available online), but they showed reduced locomotor activity during light and dark phases of the light cycle ( Figure 1D ) as well as reduced cumulative food intake during the 24 hr period ( Figure 1E ) that was accounted for by reduced intake during the dark phase of the light cycle ( Figure 1F ). To determine whether reduced food intake was due to increased satiety, we examined mice during fasting and refeeding. Male Agrp-Foxo1 À/À mice showed significantly reduced locomotor activity during an overnight fast, suggesting reduced food foraging behavior ( Figure 1G ). Moreover, they showed significantly reduced rebound food intake after an overnight fast ( Figure 1H ). In light of the role of FoxO1 in orexigenic and anorexigenic neuropeptide expression (Kitamura et al., 2006; Plum et al., 2009) , we examined AgRP and aMsh levels. After fasting, AgRP was significantly reduced in the mediobasal hypothalamus (MBH) of male Agrp-Foxo1 À/À mice, whereas aMsh was comparable to wild-type controls ( Figure 1I ). Agrp is a transcriptional target of FoxO1 (Kitamura et al., 2006) . Accordingly, we found decreased Agrp mRNA in ARH punch biopsies from overnight-fasted Agrp-Foxo1 À/À mice ( Figure 1I ). In contrast, transcript levels of the aMsh precursor, Pomc, were unaltered ( Figure 1I ). Moreover, Agrp-Foxo1 À/À mice were largely protected from high-fat diet (HDF)-induced weight gain ( Figure 1J ). These data suggest that FoxO1 in AgRP neurons is important to regulate satiety and diet-induced obesity.
Altered Hepatic Glucose Production and Gene Expression in
Given the key role of FoxO1 in hormone-dependent hepatic glucose production (HGP) (Matsumoto et al., 2007) and the effect of insulin receptor signaling in AgRP neurons on this process , we investigated the liver response to FoxO1 ablation in AgRP neurons. After acclimating mice to the calorimetry cage for >72 hr, we subjected them to an overnight fast. Shortly upon starting the fast, Agrp-Foxo1 À/À mice showed a more rapid drop of RQ than controls, but they had rebound RQ similar to controls once they were refed ( Figure 2A ). This finding indicates that fasted Agrp-Foxo1 À/À mice adapt more rapidly from carbohydrates to fatty acids as an energy source. We investigated whether this adaptation to fasting was due to an inability to mobilize hepatic glycogen. To avoid confounders due to differences in fat content (Butler and Kozak, 2010) , we performed hyperinsulinemic euglycemic clamps in mice that were closely matched for body weight and composition.
Agrp-Foxo1
À/À mice had a 50% increase in glucose infusion rates (GIR) ( Figure 2B ) and a 70% reduction of HGP ( Figure 2C ) but had comparable disposal rates (Rd) ( Figure 2D ). Furthermore, when mice were challenged with pyruvate after an overnight fast, Agrp-Foxo1 À/À mice had a significantly reduced rise in glucose levels, which is consistent with decreased hepatic gluconeogenesis ( Figures 2E and 2F ). Therefore, Agrp-Foxo1
mice show altered energy partitioning during fasting and increased metabolic flexibility. To examine mechanisms of decreased HGP, we studied Agrp-Foxo1 À/À mice after fasting and refeeding. During fasting, mRNA levels of the gluconeogenic gene G6pc were decreased ( Figure S2A ), as were those of glucokinase (Gck) ( Figure S2B ). Phosphoenolpyruvate carboxykinase-1 (Pck1) and pyruvate dehydrogenase kinase-4 (Pdk4) remained unchanged (Figure S3 ). During fasting, hepatic glycogenolysis is the main source of glucose (Lin and Accili, 2011 Figures S2F and S3 ). In contrast, hepatic Mcad was expressed at lower levels, which is consistent with the possibility that fatty acid oxidation is decreased ( Figure S2G ). Other genes involved in liver free fatty acids (FFA) metabolism were unchanged (Figure S3) . These data raised the possibility that the increased lipid accumulation in the liver of Agrp-Foxo1 À/À mice was due to increased flux of FFA from adipose tissue.
To test this hypothesis, we examined expression of lipolytic genes. Both Hsl and Atgl showed significantly increased expression after an overnight fast ( Figures 3A and 3B) , whereas Mgll showed a nonsignificant trend toward increase only at the 6 hr time point ( Figure 3C ) in Agrp-Foxo1 À/À mice. Consistently, fasting plasma FFA and glycerol were elevated ( Figures 3D and  3E ). Glucagon levels were unchanged between control and (E and F) Cumulative 24 hr (E) and dark phase food intake (F) (g of food per mouse) (n = 5-8 for each genotype).
(G) Locomotor activity during overnight fasting (n = 5 for each genotype).
(H) Rebound food intake (g/g lean body mass) after an overnight fast (n = 9 for each genotype).
(I) Hypothalamic neuropeptide (aMSH and AGRP) levels after overnight fast (n = 5-6 for each genotype). Agrp and Pomc mRNA in ARH after overnight fast (n = 6 for each genotype).
(J) Percentage of body weight gain of 10-week-old mice after switching to HFD (n = 8-9). We present data as mean ±SEM. *p < 0.05 and **p < 0.01. See also Figure S1 .
À/À mice ( Figure 3F ). Fat pad weight decreased Figure 3G ), which is consistent with increased fasting-induced lipolysis. Histomorphometry of epididymal white adipose tissue (EWAT) demonstrated significantly smaller cells in Agrp-Foxo1 À/À mice ( Figure 3H ).
Moreover, Agrp-Foxo1 À/À mice showed increased uncoupling protein 1(Ucp1) in EWAT ( Figure 3I ). Electron microscopy revealed that EWAT from Agrp-Foxo1 À/À mice contained larger mitochondria of normal morphology ( Figure 3J ).
Increased Nutrient Signaling in CNS of
The common thread in the subphenotypes observed in AgrpFoxo1 À/À mice is the dissociation between decreased food intake and reduced fasting response. These two aspects could be reconciled by increased sensitivity to hormonal and nutrient signals conveyed through AgRP neurons. To test this possibility, we looked at hormonal and nutritional signaling events. , glucose disposal (Rd) (C), and hepatic glucose production (HGP) (D) with insulin (3.6 mU/ml) (n = 6 for each genotype).
(E and F) Time course (E) and area under curve (AUC) (F) of pyruvate tolerance tests (PTT) (n = 6 for each genotype). We present data as mean ±SEM. *p < 0.05. See also Figure S2 .
Insulin and leptin inhibit food intake (Halaas et al., 1995; Woods et al., 1979) . We used immunohistochemistry with phospho (p)Akt and pStat3, respectively, to examine these signaling pathways. Fasted Agrp-Foxo1 À/À mice had increased pAkt staining in MBH that was not limited to AgRP neurons (red cells) (Figure S4A) . Western blots confirmed the increase of pAkt in MBH ( Figure 4A ). After refeeding, despite decreased serum leptin (Table S1) ,
Agrp-Foxo1
À/À mice showed increased pStat3 staining in ARH (Figures 4B and 4C) and increased hypothalamic pAkt ( Figure 4D ), especially in ARH ( Figure 4E ). Western blots confirmed the increase of pAkt in ARH (Figure 4F) . Therefore, knocking out Foxo1 in AgRP neurons renders mice more sensitive to leptin and insulin signaling in the hypothalamus. Amino acid sensing by the mammalian target of rapamycin (mTOR) pathway promotes satiety (Cota et al., 2006) . We monitored mTOR activity by immunohistochemistry with antibodies against its substrate ribosomal protein S6 in refed mice. ARH AgRP neurons project to dorso-medial hypothalamus (DMH) (Broberger et al., 1998) . Agrp-Foxo1 À/À mice showed increased pS6 staining in ARH and DMH (Figures 4G and 4H) . Thus, hormone and nutrient signaling is uniformly increased in AgrpFoxo1
mice.
Functional and Gene Expression Analysis of FoxO1-Deficient AgRP Neurons
To identify AgRP and Pomc neurons, we generated AgrpFoxo1 Rosa-Tomato;Pomc-Gfp) . Foxo1-ablated AgRP neurons expressed Npy-gfp, but not Pomc-gfp ( Figure 5A ). We conclude that FoxO1-deficient AgRP neurons retain their neuronal identity, thereby excluding developmental defects due to transdifferentiation (Padilla et al., 2010) . Next, we used AgrpFoxo1 We present data as mean ±SEM. *p < 0.05 and **p < 0.01. AU, arbitrary units. See also Figure S3 .
port chain, translation, generation of precursor metabolites and energy, mitochondrial genome maintenance, and cellular component biogenesis in FoxO1-deficient AgRP neurons (Table  S2 and Figure S4B ). This anabolic gene expression profile of the mutant neurons is consistent with a state of increased energy availability, as one would predict based on increased insulin, leptin, and mTOR signaling (Figure 4) . In other words, FoxO1-deficient AgRP neurons display gene expression patterns consistent with a state of energy sufficiency.
To explore this possibility, we examined the electrophysiological properties of AgRP neurons identified using fluorescent reporters in brain slices from wild-type and Agrp-Foxo1 À/À mice ( Figures 5D-5F ). Under basal conditions, FoxO1-deficient AgRP neurons had significantly lower membrane potential and firing frequency. Furthermore, insulin suppressed the firing frequency of wild-type cells to $35% of basal level, a nearly 3-fold reduction. Despite the lower basal firing frequency, insulin further suppressed the firing frequency of knockout neurons, with a 100-fold reduction. Insulin caused a similar reduction in membrane potential in wild-type and knockout cells ($À20mV). Therefore, the electrophysiological data are consistent with the physiologic and signaling findings in Agrp-Foxo1 À/À mice, indicating that knockout neurons are more insulin sensitive. Next, we examined expression of ion channels and neurotransmitter receptors (Table S3 and Figure S4C ). Of note, most GABAergic receptors showed increased expression, suggesting that GABAergic activity is increased, whereas most glutamatergic receptors were expressed at lower levels in FoxO1-deficient AgRP neurons, suggesting that glutamatergic signaling is decreased. To provide a functional validation of the mRNA measurements, we probed electrophysiological responses of AgRP neurons identified in brain slices from control and Agrp-Foxo1 À/À mice. Miniexcitatory postsynaptic currents (mEPSC) are typically mediated by glutamatergic neurotransmitters, whereas mini-inhibitory postsynaptic currents (mIPSC) are elicited by GABAergic neurotransmitters (Pinto et al., 2004) . FoxO1-ablated AgRP neurons showed a significant reduction of mEPSC peak amplitude ( Figure 5G ) but no change in frequency (data not shown). Conversely, they showed a significant increase of peak amplitude and size distribution of mIPSC ( Figure 5H ) without significantly altered frequency (data not shown). Therefore, the electrophysiological findings corroborate the results from gene expression profiling and indicate that Foxo1 ablation in AgRP neurons leads to increased GABAergic and decreased glutamatergic responses, as might be expected from altered neurotransmitter receptor expression at the postsynaptic level. Presynaptic plasticity of NPY neurons in ob/ob mice is modulated by acute exposure to leptin (Pinto et al., 2004) . The changes at the postsynaptic level could partly contribute to or reflect adaptive consequences of the anorexigenic phenotype in Agrp-Foxo1 À/À mice.
G-Protein-Coupled Receptor Gpr17 Is a FoxO1 Target in AgRP Neurons
Given the favorable metabolic profile of Agrp-Foxo1 À/À mice, we sought to identify FoxO1 targets that mediate its effects and are readily targetable by chemical means. Our microarray analysis (B-E and G-H) Representative immunohistochemistry with pStat3 (B and C), pAkt (D and E), and pS6 (G and H) in mice fasted overnight and refed for 3-4 hr (n = 6 for each genotype). Scale bar, 100 mm. We present data as mean ±SEM. ***p < 0.001. See also Figure S4 and Table S1 .
indicated that mRNA encoding the G-protein-coupled receptor Gpr17 was profoundly decreased in flow-sorted FoxO1-deficient AgRP neurons. Gpr17 has been deorphanized as a dual receptor for uracil nucleotides and cysteinyl-leukotrienes (Ciana et al., 2006) . Inhibition of Gpr17 in vivo can reduce ischemic damage in rodents, presumably by lowering neuronal excitability (Ciana et al., 2006) . In addition, purinergic receptors, including Gpr17, have been widely reported to modulate Ca 2+ and K + Figure 5 . FACS, RNA Profiling, and Electrophysiology of AgRP Neurons ; Rosa-tomato mice carrying an Npy-Gfp or Pomc-Gfp transgene. FoxO1-deficient AgRP neurons (red) retain Npy-Gfp expression (green, top), giving rise to merged yellow color (top), whereas they fail to colocalize with Pomc-Gfp (green, bottom). Scale bar, 100 mm. and size distribution (right) (mEPSC n = 30 and mIPSC n = 27-29 for each genotype). We present data as mean ±SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. See also Tables S2 and S3. channels and neurotransmitter receptors (Fischer and Krü gel, 2007; Pugliese et al., 2009 ). However, neither the role of Gpr17 in satiety and glucose homeostasis nor its CNS distribution is known (Chen et al., 2009; Lecca et al., 2008) . To examine the latter point, we labeled neurons with Rfp by intercrossing Synapsin-Cre and Rosa-Tomato mice, then flow-sorted neuron and nonneuron populations and measured Gpr17 levels. Quantitative PCR (qPCR) analysis showed that Gpr17 is overwhelmingly enriched in neurons ( Figure 6A ). Next, we examined Gpr17 regulation in ARH punch biopsies from fasted and refed mice. Gpr17 was expressed at significantly higher levels during fasting (Figure 6B) . To investigate the function of Gpr17 in AgRP neurons, we tested the electrophysiological properties of fluorescently labeled AgRP neurons in response to the Gpr17 antagonist, cangrelor. Upon treatment with cangrelor, AgRP neurons showed significantly reduced firing frequency and lower membrane potential ( Figures 6C-6E ). Therefore, inhibition of Gpr17 can affect the electrical activity of AgRP neurons in an insulinmimetic fashion, supporting our hypothesis. Consistent with the microarray data, Gpr17 expression in FoxO1-deficient AgRP neurons ( Figure 6F ) was dramatically reduced (18-fold over control) ( Figure 6G ). Gpr17 levels are extremely high in AgRP neurons, being comparable to b-actin (qPCR Ct = 18.44 ± 0.02 versus 20.61 ± 0.06 for b-actin and Gpr17, respectively). Foxo1, in contrast, is considerably less abundant (Ct = 23.43 ± 0.03).
We investigated the possibility that Gpr17 is a direct FoxO1 target. We found potential FoxO1-binding sites by analyzing the mouse Gpr17 promoter. Accordingly, chromatin immunoprecipitation (ChIP) assays showed that FoxO1 binds to the Gpr17 promoter ( Figure 6H) . Furthermore, quantitative analysis of the ChIP data indicated a 40-fold enrichment of the FoxO1 ChIP compared with IgG controls, indicating that binding is extremely robust.
Next, we used cultured Neuro2A cells to test the role of FoxO1 in Gpr17 regulation. Endogenous Foxo1 and Gpr17 are expressed at low levels in this cell line. Transfection of either wild-type FoxO1-Gfp or constitutively active FoxO1 (FoxO1-alanine-aspartic acid-alanine [ADA] , in which the key phosphorylation sites have been mutated in order to prevent FoxO1 inactivation) (Nakae et al., 2003) significantly increased Gpr17 levels ( Figure 6I ).
Opposing Actions of GPR17 Agonists and Antagonists on AgRP Neuron Signaling and Food Intake In Vivo
To test whether Gpr17 function affects ARH hormonal signaling in vivo, we delivered cangrelor directly into the third ventricle of mice after an overnight fast and determined the colocalization of pStat3, pS6, and pAkt with either POMC or AgRP neurons, which were identified by fluorescent reporter, after refeeding. Cangrelor treatment specifically and dramatically increased pStat3 content in AgRP neurons, but not in POMC neurons (Figure 7A , compare yellow fluorescence in the third row and lack thereof in the second row). Cangrelor also increased pAkt (Figure 7B , third row) and pS6 ( Figure 7C , third row) in a subset of AgRP neurons without effecting detectable changes in POMC neurons, as indicated by the dearth of yellow merged fluorescence in the POMC neuron panels ( Figures 7B and 7C , second row panels). This striking result indicates that Gpr17 antagonism can directly and specifically increase pStat3 content in AgRP neurons in vivo, with lesser increases in pS6 and pAkt. The specificity of the effect of cangrelor in AgRP neurons may not be unrelated to the fact that Gpr17 mRNA is exceedingly abundant in this cell type.
To interrogate the consequences of these biochemical changes, we assessed the effect of delivering cangrelor into the third ventricle of mice on food intake. In wild-type mice, we detected a significant decrease of food intake starting 1 hr after refeeding ( Figure 7D ). Consistent with our previous data (Figure 1) , Agrp-Foxo1 À/À mice had a significantly decreased refeeding intake during the same period of time that was completely unaffected by cangrelor administration. Next, we examined the consequences of activating Gpr17 in vivo. First, we delivered LTD4 directly into the third ventricle of mice after an overnight fast and determined the colocalization of pStat3 with AgRP neurons after refeeding. LTD4 treatment decreased pStat3 content in AgRP neurons ( Figure 7E , compare yellow fluorescence in the first and second rows and lack thereof in the third row). Second, based on data indicating a synergistic effect of the two classes of Gpr17 ligands (purines and leukotrienes) on Gpr17 signaling (Daniele et al., 2011) , we infused uridyl-diphosphate (UDP)-Glucose and LTD4 into the third ventricle of satiated mice and measured food intake. Activating Gpr17 by this approach rapidly induced food intake in wild-type mice, but not in Agrp-Foxo1 À/À mice ( Figure 7F ).
Thus, functional data support the hypothesis that Gpr17 is a direct FoxO1 target and that its decreased expression mediates, at least partly, the anorexigenic phenotype of AgrpFoxo1 À/À mice.
DISCUSSION
In this work, we present three important findings ( Figure 7G ): (1) transcription factor FoxO1 exerts integrative control of leptin, insulin, and amino acid signaling in AgRP neurons, effectively coordinating food intake with peripheral metabolism; (2) the identification of a heretofore unrecognized FoxO1 pathway that regulates food intake through the G protein-coupled receptor, Gpr17; and (3) the profound decrease of HGP following FoxO1 ablation in AgRP neurons, effectively unifying direct and indirect regulation of HGP control under a FoxO1-dependent mechanism. The availability of Gpr17 inhibitors in the clinic lends potential relevance to our findings, providing impetus to explore this pathway for the pharmacological treatment of obesity.
ARH Hormone Signaling Integrates Satiety and Energy Homeostasis
Central nervous system (CNS) resistance to the two anorexient hormones insulin and leptin is likely to be an early contributor to the progressive weight gain that is associated with a ''Western'' lifestyle (Schwartz et al., 2003) . In addition to a plethora of genetic studies indicating that various subpopulations of ARH neurons control body weight, decreased leptin signaling through Jak-Stat has been demonstrated early on during the progression of diet-induced obesity (Gautron and Elmquist, 2011) . We have been attracted to studying FoxO1 because of its brisk regulation in response to hormones and nutrients but also because it straddles leptin and insulin CNS signaling by virtue of its opposing actions on Agrp and Pomc expression (Kim et al., 2006; Kitamura et al., 2006) . Similar to FoxO1 ablation, transgenic overexpression of constitutive activated Stat3 in AgRP neurons leads to leanness, but not as a result of decreased food intake (Mesaros et al., 2008) . Moreover, constitutively active Stat3 causes feedback inhibition of leptin and insulin signaling (Ernst et al., 2009 ). These findings suggest that it is necessary to simultaneously sensitize both signaling pathways to engender an anorexient response. This contention is borne out from studies in POMC neurons, in which ablation of either insulin or leptin receptor had modest consequences on metabolism and energy balance (Balthasar et al., 2004; Shi et al., 2008) , whereas combined ablation caused systemic insulin resistance and female infertility (Hill et al., 2010 ). Our studies demonstrate phenotypes in Agrp-Foxo À/À mice that are not readily detectable by manipulating either insulin or leptin pathways alone.
Reconciling Direct and Indirect Mechanisms of HGP Control
The substantial decrease of HGP in Agrp-Foxo1 À/À mice provides an unexpected answer to the longstanding question on the relative roles of direct and indirect mechanisms of insulin control over HGP. We have shown that ablation of FoxO1 in the liver (Matsumoto et al., 2007) reduced glucose production to the point of causing fasting hypoglycemia (Haeusler et al., 2010) . The present data are noteworthy in a couple of respects: they show that the indirect control of insulin on HGP through the CNS is mediated through the same signaling module utilized in the liver, and they also show that such control trumps the role of FFA and glycerol (Lewis et al., 1995) because Agrp-Foxo1 À/À mice show decreased HGP in the face of elevated levels of these metabolites. Our data expand the conclusions reached in mice lacking insulin receptors in AgRP neurons, indicating that the failure of insulin inhibition of HGP in that model likely results from unchecked FoxO1 activity . We should point out that we endeavored to select mice with closely matched body weight and composition for the clamps. Thus, the decrease in HGP appears to occur independently of changes to energy balance and provides (admittedly circumstantial) evidence that insulin control of liver metabolism through the CNS occurs independently of its effects on energy balance. Future studies are warranted to test how this regulation is achieved and to identify effector pathways. The accelerated transition from carbohydrate-based to lipidbased metabolism in Agrp-Foxo1 À/À mice is consistent with increased metabolic flexibility. It might be compensatory of their inability to mobilize hepatic glycogen, or it might reflect increased sympathetic tone of adipose tissue, as suggested by increased lipase expression, Ucp1 levels, and mitochondrial (G) Under fasting conditions (nuclear FoxO1, indicated by the green color), Gpr17 is induced and modulates ion channel activity, leading to increased orexigenic neuropeptide secretion as well as glutamatergic activity (+ labeled synapse) and also contributing to food intake and HGP. Under fed conditions (phenocopied by the FoxO1 knockout), insulin and leptin signaling concur to inactivate Foxo1 and reduce Gpr17 expression. Together with increased GABAergic activity (-labeled synapse), this leads to decreased food intake and HGP.
content. The latter interpretation would be consistent with the phenotype of mice lacking Pten in leptin receptor neurons , although the present phenotype is considerably milder.
Anabolic Profile of FoxO1-Deficient AgRP Neurons
The combination of immunohistochemical and gene profiling studies in Agrp-Foxo1 À/À mice provides unprecedented insight into the mechanics of hypothalamic FoxO1 signaling. The data show increased basal and hormone-dependent signaling, which is consistent with a state of chronic inhibition of the electrical activity of these neurons. This conclusion is supported by the unusual and remarkable gene expression profile of FoxO1-deficient AgRP neurons, with increased anabolic pathways related to electron transport chain, translation, generation of precursor metabolites and energy, mitochondrial genome maintenance, and cellular component biogenesis. Thus, we suggest that the decreased food intake could be secondary to this increased anabolic activity. Consistently, mTOR pathway signaling in neurons is linked to feeding behavior (Cota et al., 2006) . Combined expression patterns of the relevant receptors, as well as electrophysiological properties of FoxO1-deficient AgRP neurons, are likely to increase GABAergic and diminish glutamatergic tone, a condition that would be expected to decrease food intake and increase metabolic flexibility. This is conceptually consistent with recent findings indicating that changes in energy storage and metabolic status in AgRP neurons are associated with altered neurotransmitter release and feeding behavior (Kaushik et al., 2011; Liu et al., 2012; Yang et al., 2011) . We postulate that this could stem from adaptation to increased sensitivity to hormonal and nutrient cues.
Therapeutic Prospects
Desirable as it might be to inhibit FoxO1 to treat metabolic diseases, this transcription factor is a poor drug target (Pajvani et al., 2011) . Hence, we sought to identify a vicarious pathway with better therapeutic prospects. Gpr17 meets several criteria in this respect: we show it to be abundant in AgRP neurons, regulated by nutritional status, and a FoxO1 target. Moreover, Gpr17 antagonists mimic the effects of FoxO1 ablation on hypothalamic hormone signaling. Importantly, pharmacological inhibition of this receptor inhibits food intake, providing a ready alternative to FoxO1 inhibition. About one-third of all approved drugs target G-protein-coupled receptors (Erlinge, 2011) . Gpr17 antagonists are currently in clinical use for the treatment of asthma by inhibiting leukotriene release (e.g., montelukast and pranlukast), and cangrelor has been used as a short-acting antiplatelet aggregation agent (Kastrati and Ndrepepa, 2009) . Therefore, the hypothesis emerging from our studies should be easily testable.
The broad distribution of Gpr17 in the CNS raises obvious concerns regarding its suitability as a target for the treatment of obesity. These concerns are partly allayed by the demonstration that direct ICV infusion of the Gpr17 antagonist cangrelor resulted in a remarkably specific activation of Stat3 phosphorylation in AgRP neurons ( Figure 7A ), whereas the agonist LTD4 caused a decrease of phospho-Stat3 ( Figure 7E ). This is consistent with our observation that Gpr17 levels are extraordinarily high in this cell type (only two cycles less abundant than actin by qPCR), and thus AgRP neurons might be singularly sensitive to manipulations of Gpr17 despite the latter's broad distribution. There are currently no reported metabolic effects of these treatments, but this may simply reflect pharmacokinetics, CNS bioavailability, or confounders from the multiple comorbidities associated with each therapeutic indication. Further work is necessary before Gpr17 can be declared a bona fide target for intervention in obesity, but our observations provide impetus to pursue this research. (Paik et al., 2007) and genotyped them as previously described. We excluded from analyses Agrp-Foxo1 À/À mice that showed somatic recombination owing to stochastic embryonic expression of Agrp-ires-Cre.
Metabolic Analyses
We measured food intake and refeeding response as described (Plum et al., 2009 ) by using a TSE Labmaster Platform (TSE Systems) for indirect calorimetry and activity measurements (Banks et al., 2008) . We performed glucose clamps as described (Okamoto et al., 2005) . We used ELISA for leptin, insulin, and glucagon measurements (Millipore) and used colorimetric assays for plasma FFA and glycerol (Wako).
Stereotactic Injections
We performed stereotactic manipulations in 3-to 4-month-old C57BL/6 mice. We placed cannulae and allowed 1 week for recovery (À1.8 mm anterior and 0 mm lateral to bregma and 5.3 mm below the skull surface). We verified correct positioning of the cannulae by monitoring drinking activity after angiotensin injection. After an overnight fast and 20 min before refeeding, we injected cangrelor (0.455 nmol) into the third ventricle and measured food intake at the times indicated. For immunohistochemistry studies, we perfused mice 4-5 hr after refeeding. We infused LTD4 0.02 nmol and UDPglucose 0.45 nmol into the third ventricle of satiated mice and measured food intake afterwards.
Immunostaining
We processed mouse brains and cut 10-mm-thick coronal sections for immunohistochemistry as described (Plum et al., 2009 ) by using pAkt (Cell Signaling 4060), pStat3 (Cell Signaling 9131), and pS6 antibodies (Cell Signaling 4858) and also Foxo1 antibody (Santa Cruz, FKHR-H128, sc11350).
RNA Procedures
We extracted RNA with Trizol (Invitrogen) and reverse transcribed with Superscript II reverse transcriptase. We performed quantitative PCR using primers spanning introns. Primer sequences are available upon request.
Western Blotting
We used radio immunoprecipitation assay (RIPA) buffer to extract protein and loaded an equal amount of protein for gel electrophoresis.
Chromatin Immunoprecipitation Assays
We isolated intact chromatin from cultured N2A cells by using ChIP-IT Express Enzymatic Kit (Active Motif). Putative Foxo1 binding site on the Gpr17 promoter was identified by genomatrix software. Multiple pairs of primers were used for the subsequent amplification of Gpr17 promoter and yielded the same result. The pair used for electrophoresis is (forward) 5 0 -CCACAC AGCTTATGTAGCATTGAGG-3 0 and (reverse) 5 0 -AGCAGGAAGGTCTCAGT AACTCCC-3 0 .
Hypothalamic Neuropeptide Assays
We prepared acid extracts from mediobasal hypothalamus and measured AgRP and aMsh as previously described (Plum et al., 2009 ). We used high-pressure liquid chromatography (HPLC) to characterize AgRP immunoreactivity. The elution profile of AgRP immunoactivity in the MBH of AgrpFoxo1 À/À and wild-type mice was similar and consisted primarily of C-terminal AgRP 83-132 , as reported (Breen et al., 2005) .
Flow Cytometry and Gene Profiling of AgRP Neurons
We dissociated mediobasal hypothalami from Agrp-Foxo1 Agrp-ires-Cre;Rfp AgRP neurons. We isolated RNA with Trizol LS reagent, amplified it (NuGEN WT-Ovation Pico RNA Amplification System), and processed it for hybridization with Affymetrix chips (GeneChip Mouse Exon 1.0 ST Array). We used GOrilla and R for pathway analysis and heat map generation.
Electrophysiology and Patch Clamp
We prepared 300 mm coronal ARH slices from 6-to 8-week-old mice by using ice-cold sucrose-based cutting solution (adjusted to pH 7.3) containing (in mM) 10 NaCl, 25 NaHCO 3 , 195 sucrose, 5 glucose, 2.5 KCl, 1.25 NaH 2 PO 4 , 2 Na pyruvate, 0.5 CaCl 2 , and 7 MgCl 2 bubbled continuously with 95% O 2 and 5% CO 2 . We allowed slices to recover for at least 45 min at room temperature in recording solution (adjusted to pH 7.3) containing (in mM) 125 NaCl, 5 glucose, 25 NaHCO 3 , 2.5 KCl, 1.25 NaH 2 PO 4 , 2 CaCl 2 , and 1 MgCl 2 bubbled continuously with 95% O 2 and 5% CO 2 before transferring them to a perfusion chamber for recording. We pulled patch pipettes to resistances of 7-9 MU and filled them with solution (adjusted to pH 7.3) containing 128 K gluconate, 10 KCl, 10 HEPES, 0.1 EGTA, 2 MgCl 2 , 0.3 Na-GTP, and 3 Mg-ATP. We selected cells by using an upright microscope fitted with fluorescence optics (Nikon) and patched under IR-DIC optics. We assessed electrical access in the whole-cell recording mode using a small-voltage step pulse before and at the end of the current clamp recordings. We discarded recordings in which the series resistance had been >15 MU. We acquired current clamp recordings with no current injection by using a MultiClamp 700B amplifier and Clampex data acquisition software (Axon Instruments). We recorded at room temperature and analyzed action potential (AP) firing frequency, membrane potential, and AP amplitude by using MiniAnalysis (Synaptosoft). Electrophysiological recording to measure mEPSC and mIPSC in brain slices was performed as previously described (Pinto et al., 2004) .
Statistical Analyses
We analyzed data with Student's t test or one-way ANOVA by using GraphPad Prism software. We used the customary threshold of p < 0.05 to declare statistical significance.
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